Levodopa treatment in Parkinson’s disease: earlier or later?

Lignende værker

• Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
  af: Eusebi, Paolo, et al.
  Udgivet: (2018)
• The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
  af: Paolini Paoletti, Federico, et al.
  Udgivet: (2020)
• A/T/(N) Profile in Cerebrospinal Fluid of Parkinson’s Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
  af: Bellomo, Giovanni, et al.
  Udgivet: (2020)
• The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
  af: Paolini Paoletti, Federico, et al.
  Udgivet: (2021)
• Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
  af: Farotti, Lucia, et al.
  Udgivet: (2020)